CRV431

· Hepion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRV431, covering 2022-07-15 to 2022-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects [Phase 2]